Key result
LDL-C level was independently associated with the presence of subclinical coronary atherosclerosis in individuals without traditional risk factors.
Why the study?
Individuals without traditional cardiovascular risk factors still experience adverse events in clinical practice, prompting evaluation of predictors of subclinical coronary atherosclerosis in this population.
Is LDL-C level associated with subclinical coronary atherosclerosis in asymptomatic individuals without traditional cardiovascular risk factors?
Cross-Sectional (n=1,250)
Is LDL-C level associated with subclinical coronary atherosclerosis in asymptomatic individuals without traditional cardiovascular risk factors?
LDL-C levels, even when considered within the normal range, are independently associated with subclinical coronary atherosclerosis in asymptomatic individuals without traditional cardiovascular risk factors.
Answers are grounded in this paper and cite their sources.
Subclinical atherosclerosis links to modifiable factors even below thresholds; leaves open whether tighter targets warrant trials in low-risk individuals.
AIMS: Individuals without traditional cardiovascular risk factors (CVRFs) still experience adverse events in clinical practice. This study evaluated the predictors of subclinical coronary atherosclerosis in individuals without traditional CVRFs. METHODS AND RESULTS: A total of 1250 (52.8 ± 6.5 years, 46.9% male) asymptomatic individuals without CVRFs who underwent coronary computed tomographic angiography for a general health examination were analysed. The following were considered as traditional CVRFs: systolic/diastolic blood pressure ≥140/90 mmHg; fasting glucose ≥126 mg/dL; total cholesterol ≥240 mg/dL; low-density lipoprotein cholesterol (LDL-C) ≥160 mg/dL; high-density lipoprotein cholesterol <40 mg/dL; body mass index ≥25.0 kg/m2; current smoking status; and previous medical history of hypertension, diabetes, and dyslipidaemia. Subclinical atherosclerosis, defined as the presence of any coronary plaque, was present in 20.6% cases; the incidences of non-calcified, calcified, and mixed plaque were 9.6%, 12.6%, and 2.6%, respectively. Multivariate regression analysis showed that LDL-C level [odds ratio (OR): 1.008; 95% confidence interval (CI): 1.001-1.015], together with age (OR: 1.101; 95% CI: 1.075-1.128) and male sex (OR: 5.574; 95% CI: 3.310-9.388), was associated with the presence of subclinical atherosclerosis (All P < 0.05). LDL-C level was significantly associated with an increased risk of calcified plaques rather than non-calcified or mixed plaques. CONCLUSION: LDL-C, even at levels currently considered within normal range, is independently associated with the presence of subclinical coronary atherosclerosis in individuals without traditional CVRFs. Our results suggest that a stricter control of LDL-C levels may be necessary for primary prevention in individuals who are conventionally considered healthy.
No takes yet. Share an insight, caveat, or question.
Won et al. (2019) conducted a cross-sectional in Subclinical coronary atherosclerosis (n=1,250). Low-density lipoprotein cholesterol (LDL-C) was evaluated on Presence of subclinical atherosclerosis (any coronary plaque) (OR 1.008, 95% CI 1.001-1.015, p=<0.05). LDL-C level was independently associated with the presence of subclinical coronary atherosclerosis in individuals without traditional risk factors.
Synapse has enriched 10 related papers. Consider them for comparative context: